Alembic's Q3 FY 2025-26 Quarterly Results
- 13 Feb 2026
Result Summary
- Alembic Ltd reported a 36.5% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 23.1%.
- Its expenses for the quarter were up by 41.4% QoQ and 45.8% YoY.
- The net profit decreased 53.2% QoQ and decreased 8.0% YoY.
- The earnings per share (EPS) of Alembic Ltd stood at 2.34 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 76.65 | 120.78 | 62.29 | -36.5% | 23.1% |
Total Expenses | 50.89 | 36.00 | 34.90 | 41.4% | 45.8% |
Profit Before Tax | 25.76 | 84.78 | 27.39 | -69.6% | -6.0% |
Tax | 3.29 | 8.72 | 1.30 | -62.3% | 153.1% |
Profit After Tax | 60.13 | 128.49 | 65.39 | -53.2% | -8.0% |
Earnings Per Share | 2.34 | 5.00 | 2.55 | -53.2% | -8.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Alembic Ltd is a well-established company known for its operations in the pharmaceutical industry. The company primarily focuses on manufacturing and marketing pharmaceutical products, including formulations and active pharmaceutical ingredients. As a player in the healthcare sector, Alembic Ltd has been involved in the development and distribution of a wide range of therapeutic products. While specific recent developments about Alembic Ltd are not provided in the data, the company has historically been involved in expanding its market reach and enhancing its product portfolio to meet the growing demands of the healthcare industry.
Revenue
During the third quarter of FY26, Alembic Ltd reported a total income of ₹76.65 crores. This represents a significant decline of 36.5% compared to the previous quarter (Q2FY26), where the total income was ₹120.78 crores. However, on a year-over-year basis, there is an observable increase of 23.1% from the total income of ₹62.29 crores in Q3FY25. These figures indicate changes in the company's revenue generation over the quarters and the past year, reflecting variations in sales or other income sources.
Profitability
Alembic Ltd's profit before tax in Q3FY26 was ₹25.76 crores, which marks a substantial decrease of 69.6% from the previous quarter's profit before tax of ₹84.78 crores. When compared to the same quarter in the previous year (Q3FY25), this represents a 6.0% decrease from ₹27.39 crores. The company incurred a tax expense of ₹3.29 crores in Q3FY26, which is 62.3% less than the previous quarter but 153.1% higher than Q3FY25. Consequently, the profit after tax for Q3FY26 stands at ₹60.13 crores, reflecting a 53.2% decrease quarter-over-quarter and an 8.0% decrease year-over-year. Earnings per share also followed a similar trend, recorded at ₹2.34 in Q3FY26 compared to ₹5.00 in the previous quarter and ₹2.55 in the same quarter last year.
Operating Metrics
The total expenses for Alembic Ltd in Q3FY26 were ₹50.89 crores, marking a 41.4% increase from the previous quarter's expenses of ₹36.00 crores and a 45.8% rise from Q3FY25's expenses of ₹34.90 crores. This indicates significant changes in the company's cost structure over the last quarter and year, which could be due to various factors such as increased operational costs or strategic investments. The financial performance of the company, as reflected in its profitability metrics, shows notable fluctuations in earnings and expenses, which are essential for understanding the company's operational efficiency and cost management practices during this period.